Diethylcarbamazine (Dec) Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 100 mg
Reference Brands: Generic formulations available in various generic brands
Category: Anthelmintic
Diethylcarbamazine (DEC) inhibits microfilariae and adult filarial worms, disrupting their metabolism and immune evasion. It effectively treats filariasis and tropical parasitic infections, reducing symptoms, preventing disease transmission, and supporting overall health. Benefits include parasite elimination, symptom relief, and improved quality of life in affected regions. Diethylcarbamazine (DEC) tablet is available in Tablets and strengths such as 100 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Diethylcarbamazine (DEC) tablet is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Diethylcarbamazine (DEC) tablet can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Diethylcarbamazine (DEC) tablets, marketed as Eletcroos and generics, are approved in the US by the FDA and in the EU via EMA for treating lymphatic filariasis and tropical parasitic infections. Regulatory approval requires dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, clinical trial and quality data review facilitate approval, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports timely approval, safe use, and global availability, aiding in parasite control and disease prevention worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Diethylcarbamazine is used for treating parasitic infections caused by filarial worms, mainly lymphatic filariasis, loa loa infection, and tropical pulmonary eosinophilia. It helps reduce parasite load in the blood and improves symptoms related to these infections.
Diethylcarbamazine is made from the active pharmaceutical ingredient diethylcarbamazine citrate, a synthetic anti-filarial compound.
The commonly known trade name is Banocide.
Several pharmaceutical companies manufacture Diethylcarbamazine, including GSK (originally for Banocide) and multiple Indian manufacturers producing generic versions.
The generic name is diethylcarbamazine citrate.
Brand name is Banocide.
Diethylcarbamazine is manufactured in several countries, with India being one of the primary producers due to high global demand for filariasis control programs.
Related Products
Mefloquine Hydrochloride
Strength:
250 mg
Form: Tablets
Reference Brands: Lariam (USA/EU)
View Details
Praziquantel Tablets
Strength:
600 mg
Form: Tablets
Reference Brands: Biltricide(US & EU)
View Details
Pyrantel Pamoate Chewable Tablets
Strength:
11 mg
Form: Tablets
Reference Brands: Pin-X(US),Combantrin(EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
